Statins and delirium during critical illness: A multicenter, prospective cohort study

Critical Care Medicine

Volumn 42, Issue 8, 2014, Pages 1899-1909

  Morandi, Alessandro ^a,b,c   Hughes, Christopher G ^c,d   Thompson, Jennifer L ^c   Pandharipande, Pratik P ^c,d   Shintani, Ayumi K ^c   Vasilevskis, Eduard E ^c,e   Han, Jin H ^c   Jackson, James C ^c,d   Laskowitz, Daniel T ^f   Bernard, Gordon R ^c   Ely, E Wesley ^c,e   Girard, Timothy D ^c,e  

^a Hospital Ancelle   (Italy)

^b GERIATRIC RESEARCH GROUP   (Italy)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cognition; critical illness; delirium; hydroxymethylglutaryl CoA reductase inhibitors; intensive care units; sepsis

Indexed keywords

ADRENALIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ATORVASTATIN; DEXMEDETOMIDINE; DOBUTAMINE; DOPAMINE; FENTANYL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MIDAZOLAM; MILRINONE; NEUROLEPTIC AGENT; NORADRENALIN; PHENYLEPHRINE; PRAVASTATIN; PROPOFOL; ROSUVASTATIN; VASOPRESSIN;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ANTIBIOTIC THERAPY; APACHE; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CRITICAL ILLNESS; DELIRIUM; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SHOCK; UNITED STATES; CLINICAL TRIAL; COMORBIDITY; INTENSIVE CARE; MIDDLE AGED; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS-ASSOCIATED ENCEPHALOPATHY; TENNESSEE; TERTIARY CARE CENTER; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SEPSIS-ASSOCIATED ENCEPHALOPATHY; TENNESSEE; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84904752943     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000398     Document Type: Article

References (57)

1. Adhikari NK, Fowler RA, Bhagwanjee S, et al: Critical care and the global burden of critical illness in adults. Lancet 2010; 376:1339-1346
2. Girard TD, Jackson JC, Pandharipande PP, et al: Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010; 38:1513-1520
3. Thomason JW, Shintani A, Peterson J F, et al: Intensive care unit delirium is an independent predictor of longer hospital stay: A prospective analysis of 261 non-ventilated patients. Crit Care 2005; 9:R375-R381
4. Shehabi Y, Riker RR, Bokesch PM, et al; SEDCOM (Safety and Effcacy of Dexmedetomidine Compared With Midazolam) Study Group: Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med 2010; 38: 2311-2318
5. Ely EW, Shintani A, Truman B, et al: Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004; 291:1753-1762
6. Pisani MA, Kong SY, Kasl SV, et al: Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009; 180:1092-1097
7. Milbrandt EB, Deppen S, Harrison PL, et al: Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004; 32:955-962
8. National Center for Health Statistics: Health, United States, 2010: With Special Feature on Death and Dying. Hyattsville, MD, National Center for Health Statistics, 2011
9. Rosenson RS, Tangney CC, Casey LC: Inhibition of proinfammatory cytokine production by pravastatin. Lancet 1999; 353:983-984
10. Dichtl W, Dulak J, Frick M, et al: HMG-CoA reductase inhibitors regulate infammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003; 23:58-63
11. Pleiner J, Schaller G, Mittermayer F, et al: Simvastatin prevents vascular hyporeactivity during infammation. Circulation 2004; 110:3349-3354
12. McGown CC, Brown NJ, Hellewell PG, et al: Benefcial microvascu-lar and anti-infammatory effects of pravastatin during sepsis involve nitric oxide synthase III. Br J Anaesth 2010; 104:183-190
13. Bourcier T, Libby P: HMG CoA reductase inhibitors reduce plas-minogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20:556-562
14. Steiner S, Speidl WS, Pleiner J, et al: Simvastatin blunts endo-toxin-induced tissue factor in vivo. Circulation 2005; 111: 1841-1846
15. Morandi A, Hughes CG, Girard TD, et al: Statins and brain dysfunction: A hypothesis to reduce the burden of cognitive impairment in patients who are critically ill. Chest 2011; 140:580-585
16. Maclullich AM, Ferguson KJ, Miller T, et al: Unravelling the pathophysi-ology of delirium: A focus on the role of aberrant stress responses. J Psychosom Res 2008; 65:229-238
17. Gunther ML, Morandi A, Ely EW: Pathophysiology of delirium in the intensive care unit. Crit Care Clin 2008; 24:45-65, viii
18. Shyamsundar M, McKeown ST, O'Kane CM, et al: Simvastatin decreases lipopolysaccharide-induced pulmonary infamma-tion in healthy volunteers. Am J Respir Crit Care Med 2009; 179: 1107-1114
19. Craig TR, Duffy MJ, Shyamsundar M, et al: A randomized clinical trial of hydroxymethylglutaryl-coenzyme a reductase inhibition for acute lung injury (the HARP study). Am J Respir Crit Care Med 2011; 183:620-626
20. Kruger P, Bailey M, Bellomo R, et al; ANZ-STATInS Investigators-ANZICS Clinical Trials Group: A multicenter randomized trial of ator-vastatin therapy in intensive care patients with severe sepsis. Am J Respir Crit Care Med 2013; 187:743-750
21. Sposito AC, Carvalho LS, Cintra RM, et al; Brasilia Heart Study Group: Rebound infammatory response during the acute phase of myocardial infarction after simvastatin withdrawal. Atherosclerosis 2009; 207:191-194
22. Heeschen C, Hamm CW, Laufs U, et al; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators: Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 2002; 105:1446-1452
23. Tseng MY, Czosnyka M, Richards H, et al: Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic defcits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 2005; 36: 1627-1632
24. Blanco M, Nombela F, Castellanos M, et al: Statin treatment withdrawal in ischemic stroke: A controlled randomized study. Neurology 2007; 69:904-910
25. Le Manach Y, Godet G, Coriat P, et al: The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 2007; 104: 1326-1333
26. Bell CM, Brener SS, Gunraj N, et al: Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA 2011; 306:840-847
27. Redelmeier DA, Thiruchelvam D, Daneman N: Delirium after elective surgery among elderly patients taking statins. CMAJ 2008; 179:645-652
28. Katznelson R, Djaiani GN, Borger MA, et al: Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery. Anesthesiology 2009; 110:67-73
29. Mariscalco G, Cottini M, Zanobini M, et al: Preoperative statin therapy is not associated with a decrease in the incidence of delirium after cardiac operations. Ann Thorac Surg 2012; 93: 1439-1447
30. Hughes CP, Berg L, Danziger WL, et al: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572
31. Pandharipande PP, Girard TD, Jackson JC, et al; BRAIN-ICU Study Investigators: Long-term cognitive impairment after critical illness. N Engl J Med 2013; 369:1306-1316
32. Ely EW, Inouye SK, Bernard GR, et al: Delirium in mechanically ventilated patients: Validity and reliability of the Confusion Assessment Method for the intensive care unit (CAM-ICU). JAMA 2001; 286:2703-2710
33. Ely EW, Margolin R, Francis J, et al: Evaluation of delirium in critically ill patients: Validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001; 29: 1370-1379
34. Guenther U, Popp J, Koecher L, et al: Validity and reliability of the CAM-ICU Flowsheet to diagnose delirium in surgical ICU patients. J Crit Care 2010; 25:144-151
35. Luetz A, Heymann A, Radtke FM, et al: Different assessment tools for intensive care unit delirium: Which score to use? Crit Care Med 2010; 38:409-418
36. Jorm AF: A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Development and cross-validation. Psychol Med 1994; 24:145-153
37. Jorm AF, Scott R, Cullen JS, et al: Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol Med 1991; 21:785-790
38. D'Agostino RB, Wolf PA, Belanger AJ, et al: Stroke risk profle: Adjustment for antihypertensive medication. The Framingham Study. Stroke 1994; 25:40-43
39. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710
40. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-619
41. Katz S, Ford AB, Moskowitz RW, et al: Studies of illness in the aged. The index of ADL: A standardized measure of biological and psycho-social function. JAMA 1963; 185:914-919
42. Pfeffer RI, Kurosaki TT, Harrah CH Jr, et al: Measurement of functional activities in older adults in the community. J Gerontol 1982; 37: 323-329
43. Bone RC, Balk RA, Cerra FB, et al: Defnitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
44. Ihaka R, Gentleman R: R: A language for data analysis and graphics. J Comput Graph Stat 1996; 5:299-314
45. Page VJ, Davis D, Zhao XB, et al: Statin use and risk of delirium in the critically ill. Am J Respir Crit Care Med 2014; 189:666-673
46. Semmler A, Hermann S, Mormann F, et al: Sepsis causes neuro-infammation and concomitant decrease of cerebral metabolism. J Neuroinfammation 2008; 5:38
47. van Gool WA, van de Beek D, Eikelenboom P: Systemic infection and delirium: When cytokines and acetylcholine collide. Lancet 2010; 375:773-775
48. Girard TD, Ware LB, Bernard GR, et al: Associations of markers of infammation and coagulation with delirium during critical illness. Intensive Care Med 2012; 38:1965-1973
49. Papadopoulos MC, Lamb FJ, Moss RF, et al: Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci (Lond) 1999; 96:461-466
50. Pfster D, Siegemund M, Dell-Kuster S, et al: Cerebral perfusion in sepsis-associated delirium. Crit Care 2008; 12:R63
51. Semmler A, Okulla T, Sastre M, et al: Systemic infammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat 2005; 30:144-157
52. Zacco A, Togo J, Spence K, et al: 3-hydroxy-3-methylglutaryl coen-zyme A reductase inhibitors protect cortical neurons from excitotoxic-ity. J Neurosci 2003; 23:11104-11111
53. Ponce J, de la Ossa N P, Hurtado O, et al: Simvastatin reduces the association of NMDA receptors to lipid rafts: A cholesterol-mediated effect in neuroprotection. Stroke 2008; 39: 1269-1275
54. Hughes CG, Morandi A, Girard TD, et al: Association between endo-thelial dysfunction and acute brain dysfunction during critical illness. Anesthesiology 2013; 118:631-639
55. Avorn J, Monette J, Lacour A, et al: Persistence of use of lipid-lowering medications: A cross-national study. JAMA 1998; 279: 1458-1462
56. Blackburn DF, Dobson RT, Blackburn JL, et al: Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a frst cardiovascular event: A retrospective cohort study. Can J Cardiol 2005; 21:485-488
57. Sung JC, Nichol MB, Venturini F, et al: Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Manag Care 1998; 4:1421-1430